Biophysics Unit, Department of Biochemistry and Molecular Biology, School of Medicine, Universitat Autònoma de Barcelona, 08193, Cerdanyola del Vallés, Catalonia, Spain.
Department of Biochemistry and Biophysics, Stockholm University, SE-10691, Stockholm, Sweden.
Sci Rep. 2019 Feb 4;9(1):1203. doi: 10.1038/s41598-018-37445-2.
Heterologous expression of human membrane proteins is a challenge in structural biology towards drug discovery. Here we report a complete expression and purification process of a functional human sodium/D-glucose co-transporter 1 (hSGLT1) in Pichia pastoris as representative example of a useful strategy for any human membrane protein. hSGLT1 gene was cloned in two different plasmids to develop parallel strategies: one which includes green fluorescent protein fusion for screening optimal conditions, and another for large scale protein production for structural biology and biophysics studies. Our strategy yields at least 1 mg of monodisperse purified recombinant hSGLT1 per liter of culture, which can be characterized by circular dichroism and infrared spectroscopy as an alpha-helical fold protein. This purified hSGLT1 transports co-substrates (Na and glucose) and it is inhibited by phlorizin in electrophysiological experiments performed in planar lipid membranes.
人源膜蛋白的异源表达是药物发现的结构生物学领域的一项挑战。在此,我们报告了一个功能正常的人源钠/葡萄糖协同转运蛋白 1(hSGLT1)在巴斯德毕赤酵母中的完整表达和纯化过程,这是针对任何人类膜蛋白的一种有用策略的代表性示例。hSGLT1 基因被克隆到两个不同的质粒中,以开发并行策略:一个包含绿色荧光蛋白融合,用于筛选最佳条件,另一个用于大规模蛋白质生产,用于结构生物学和生物物理学研究。我们的策略至少可以从每升培养物中获得 1 毫克单分散纯化的重组 hSGLT1,其可以通过圆二色性和红外光谱来表征为具有α-螺旋折叠结构的蛋白。这种纯化的 hSGLT1 可以转运共底物(Na 和葡萄糖),并且在平面脂质膜中进行的电生理学实验中,它可以被根皮苷抑制。